Navigation Links
PanCareSurFup: Major EU project to tackle complications of childhood cancer treatment
Date:2/2/2011

By learning more about these late effects of treatment, the health care services can, on the one hand, improve and reduce the intensity of the treatment, and, on the other hand, find appropriate ways to care for those suffering from side-effects of the treatment in adolescence and adulthood.

The cancer care services in Lund, Sweden, set up a late effects clinic for children affected by cancer as early as 1987. Twenty years later, in 2007, Lund organised the first European conference on late complications of childhood cancer.

This became the start of the EU project, PanCareSurFup (PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies), with a budget of almost EUR 6 million, which will kick off with a meeting in Lund, Sweden, at the end of this week. On Thursday, 3 February, a press conference will be held at 9:45 in Lukas Sal at the Grand Htel in Lund.

One person who has experience of childhood cancer is 24-year-old Linnea Renholm Persson. At the age of 12, she fell ill with the serious cancer known as acute myeloid leukaemia. Thanks to six months of harsh treatment, she gradually recovered without having to undergo an arduous bone marrow transplant. In the spring, Linnea is planning to move in with her partner and sometimes she wonders whether the treatment may have affected her ability to have children.

The consortium's project coordinator is paediatric oncologist Lars Hjorth from Skne University Hospital and Lund University. Epidemiologist Julie Byrne from the Boyne Research Institute in Ireland will also be in Lund for the kick-off. She is behind a number of major register studies of late complications of childhood cancer treatment.

Thirty-four other specialists are involved in the project, representing 16 institutions in 11 countries. Their task is to draw up guidelines for best clinical practice in order to cure to the greatest extent possible without causing harm.

The discussions will also address the best possible follow-up of those who currently live with side-effects of their cancer treatment from high-risk treatments that affect the kidneys and heart to low-risk cases with more indeterminable symptoms.

PanCareSurFup will run for five years and is also supported by national funding from the Swedish Childhood Cancer Foundation.


'/>"/>

Contact: Lars Hjort
lars.hjorth@med.lu.se
464-617-8273
Lund University
Source:Eurekalert

Related medicine news :

1. UCLA researchers eliminate major roadblock in regenerative medicine
2. National Academy of Sciences honors microbiologists for major scientific contributions
3. New program targeting whole-person health care gets major grant
4. One in 12 Fans Leaves Major Sports Events Drunk: Study
5. International research team reports major findings in prevention and treatment of blood clots
6. VCU findings may help explain some major clinical symptoms of preeclampsia
7. New test announced for major killer of lung transplant patients
8. Mount Sinai researchers make major breakthrough in melanoma research
9. Study reveals major shift in how eczema develops
10. Majority of U.S. Adults Had Troubled Childhoods: CDC
11. Euthymics presents phase II data for EB-1010 in major depression at ACNP annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: